Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408388 · ClinicalTrials.gov registry record
Pulse Oximeter Accuracy During Stable Hypoxia Plateaus
A clinical trial of Hypoxia, sponsored by Nihon Kohden.
- Active
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT07408388: Active study of Hypoxia, sponsored by Nihon Kohden.
NCT07408388 is a study of Hypoxia that is active but no longer recruiting, run by Nihon Kohden. The registered enrollment target is 48 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07408388, a study of Hypoxia, is active but no longer recruiting, sponsored by Nihon Kohden.
- ACTIVE NOT RECRUITING
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with healthy volunteers at rest.
Primary Outcome
Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter (SpO2) to that obtained from a blood sample (SaO2) and calculating the arithmetic root mean square (Arms) error value as follows: Arms = Square root (sum of n samples of ((SpO2i - SRi) squared) / n)
Conditions Studied
Interventions
- DEVICE Pulse Oximeter
- PROCEDURE Induced hypoxia through breathing nitrogen-air-carbon dioxide mixture
Study Locations (1)
California
- Vital Sign Research Group - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2027-12-01 |
What the registry record for NCT07408388 still lists
NCT07408388 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Pulse Oximeter is the first listed.
NCT07408388 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07408388 about?
NCT07408388 is a clinical study titled "Pulse Oximeter Accuracy During Stable Hypoxia Plateaus". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with healthy volunteers at rest.
What is the current status of trial NCT07408388?
This trial is currently active not recruiting. The enrollment target is 48 participants. The study started on 2025-12-03. Estimated completion is 2027-12-01.
What conditions does trial NCT07408388 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT07408388?
The interventions under investigation include: Pulse Oximeter (DEVICE), Induced hypoxia through breathing nitrogen-air-carbon dioxide mixture (PROCEDURE).
Who is sponsoring clinical trial NCT07408388?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408388 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07408388's enrollment target sits among peer trials
48 19th of 39 higher than 21 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI